What are the recommended treatments for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Treatment Recommendations

NSAIDs are the first-line treatment for mild to moderate migraines, while triptans are recommended for moderate to severe migraines or when NSAIDs fail. 1

Acute Treatment Algorithm

Mild to Moderate Migraines

  • First-line: NSAIDs
    • Ibuprofen 400-600mg
    • Naproxen sodium 500-550mg
    • Acetaminophen-aspirin-caffeine combination
    • Take medication early in the headache phase for maximum effectiveness 1
    • Limit use to no more than twice weekly to prevent medication overuse headache 1

Moderate to Severe Migraines

  • First-line: Triptans (serotonin 5-HT1B/D agonists)
    • Sumatriptan 50mg orally (recommended starting dose)
    • Sumatriptan 100mg may provide greater efficacy but with more side effects 1, 2
    • Sumatriptan 6mg subcutaneously for severe attacks or significant nausea/vomiting 1
    • Other options: rizatriptan, naratriptan, zolmitriptan 1
    • Maximum daily dose of sumatriptan: 200mg in a 24-hour period 2
    • If migraine hasn't resolved after 2 hours, a second dose may be administered 2

When Triptans Fail or are Contraindicated

  • Alternative options:
    • Gepants (CGRP antagonists): ubrogepant or rimegepant 1
    • Ditans (5-HT1F agonists): lasmiditan 1
    • Opioids should only be considered when other medications cannot be used and after addressing abuse risk 1

Special Considerations

Patients with Nausea/Vomiting

  • Use non-oral routes of administration:
    • Sumatriptan subcutaneous injection
    • Intranasal DHE
    • Add antiemetic medication to treat nausea 1

Patients with Hepatic Impairment

  • For mild to moderate hepatic impairment, maximum single dose of sumatriptan should not exceed 50mg 2

Timing of Medication

  • Taking medication early, during the mild pain phase, provides significantly better outcomes than treating established attacks with moderate or severe pain 3

Preventive Treatment

When to Consider Prevention

  • ≥2 migraine attacks per month with significant disability
  • Acute treatments used more than twice weekly 1

Preventive Options

  • First-line: Beta blockers (e.g., propranolol 80-240 mg/day) - high level of evidence 1
  • Other options:
    • Tricyclic antidepressants (e.g., amitriptyline 30-150 mg/day) - particularly effective for mixed migraine and tension-type headaches 1
    • Anticonvulsants 1
    • CGRP monoclonal antibodies - moderate to high level of evidence 1

Avoiding Medication Overuse Headache

  • Limit NSAIDs to no more than 15 days per month
  • Limit triptans to no more than 9 days per month
  • Limit OTC medications to no more than 14 days per month
  • Limit Ubrelvy to no more than 8 days per month 1

Non-Pharmacological Approaches

  • Regular aerobic exercise or strength training
  • Maintain regular sleep schedule
  • Adequate hydration
  • Identify and avoid triggers
  • Relaxation techniques or mindfulness
  • Neuromodulatory devices, biobehavioral therapy, and acupuncture as adjuncts or standalone treatments when medications are contraindicated 1

Efficacy and Monitoring

  • Assess treatment efficacy after 2-3 months for oral preventives and 3-6 months for CGRP monoclonal antibodies
  • Evaluate patients for high-risk factors including anxiety, depression, and medication overuse 1

Important Cautions

  • Triptans are contraindicated in patients with uncontrolled hypertension, basilar or hemiplegic migraine, and cardiovascular disease 1
  • Adverse events with sumatriptan are generally transient and mild, with a clear dose-response relationship (25mg to 100mg) 3
  • Subcutaneous administration provides more rapid pain relief than other routes but has higher rates of adverse events 4

References

Guideline

Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.